Journal of Nanobiotechnology,
Год журнала:
2024,
Номер
22(1)
Опубликована: Авг. 12, 2024
Biomaterials
are
substances
that
can
be
injected,
implanted,
or
applied
to
the
surface
of
tissues
in
biomedical
applications
and
have
ability
interact
with
biological
systems
initiate
therapeutic
responses.
Biomaterial-based
vaccine
delivery
possess
robust
packaging
capabilities,
enabling
sustained
localized
drug
release
at
target
site.
Throughout
process,
they
contribute
protecting,
stabilizing,
guiding
immunogen
while
also
serving
as
adjuvants
enhance
efficacy.
In
this
article,
we
provide
a
comprehensive
review
contributions
biomaterials
advancement
development.
We
begin
by
categorizing
biomaterial
types
properties,
detailing
their
reprocessing
strategies,
exploring
several
common
systems,
such
polymeric
nanoparticles,
lipid
hydrogels,
microneedles.
Additionally,
investigated
how
physicochemical
properties
routes
influence
immune
Notably,
delve
into
design
considerations
adjuvants,
showcasing
application
development
for
cancer,
acquired
immunodeficiency
syndrome,
influenza,
corona
virus
disease
2019
(COVID-19),
tuberculosis,
malaria,
hepatitis
B.
review,
highlight
successful
instances
where
enhanced
efficacy
discuss
limitations
future
directions
immunotherapy.
This
aims
offer
researchers
understanding
stimulate
further
progress
related
fields.
Chemical Reviews,
Год журнала:
2024,
Номер
124(9), С. 5505 - 5616
Опубликована: Апрель 16, 2024
The
recent
emergence
of
nanomedicine
has
revolutionized
the
therapeutic
landscape
and
necessitated
creation
more
sophisticated
drug
delivery
systems.
Polymeric
nanoparticles
sit
at
forefront
numerous
promising
designs,
due
to
their
unmatched
control
over
physiochemical
properties
such
as
size,
shape,
architecture,
charge,
surface
functionality.
Furthermore,
polymeric
have
ability
navigate
various
biological
barriers
precisely
target
specific
sites
within
body,
encapsulate
a
diverse
range
cargo
efficiently
release
this
in
response
internal
external
stimuli.
However,
despite
these
remarkable
advantages,
presence
wider
clinical
application
is
minimal.
This
review
will
provide
comprehensive
understanding
vehicles.
affecting
be
outlined
first,
followed
by
description
nanoparticle
designs
preparation
methods,
beginning
with
polymers
on
which
they
are
based.
meticulously
explore
current
performance
against
myriad
diseases
including
cancer,
viral
bacterial
infections,
before
finally
evaluating
advantages
crucial
challenges
that
determine
potential
decades
come.
Signal Transduction and Targeted Therapy,
Год журнала:
2024,
Номер
9(1)
Опубликована: Авг. 12, 2024
Cancer
remains
a
significant
risk
to
human
health.
Nanomedicine
is
new
multidisciplinary
field
that
garnering
lot
of
interest
and
investigation.
shows
great
potential
for
cancer
diagnosis
treatment.
Specifically
engineered
nanoparticles
can
be
employed
as
contrast
agents
in
diagnostics
enable
high
sensitivity
high-resolution
tumor
detection
by
imaging
examinations.
Novel
approaches
labeling
are
also
made
possible
the
use
nanoprobes
nanobiosensors.
The
achievement
targeted
medication
delivery
therapy
accomplished
through
rational
design
manufacture
nanodrug
carriers.
Nanoparticles
have
capability
effectively
transport
medications
or
gene
fragments
tissues
via
passive
active
targeting
processes,
thus
enhancing
treatment
outcomes
while
minimizing
harm
healthy
tissues.
Simultaneously,
context
radiation
sensitization
photothermal
enhance
therapeutic
efficacy
malignant
tumors.
This
review
presents
literature
overview
summary
how
nanotechnology
used
According
oncological
diseases
originating
from
different
systems
body
combining
pathophysiological
features
cancers
at
sites,
we
most
recent
developments
applications.
Finally,
briefly
discuss
prospects
challenges
cancer.
ACS Omega,
Год журнала:
2023,
Номер
8(24), С. 21391 - 21409
Опубликована: Июнь 7, 2023
Biofilm-associated
infections
have
emerged
as
a
significant
public
health
challenge
due
to
their
persistent
nature
and
increased
resistance
conventional
treatment
methods.
The
indiscriminate
usage
of
antibiotics
has
made
us
susceptible
range
multidrug-resistant
pathogens.
These
pathogens
show
reduced
susceptibility
intracellular
survival.
However,
current
methods
for
treating
biofilms,
such
smart
materials
targeted
drug
delivery
systems,
not
been
found
effective
in
preventing
biofilm
formation.
To
address
this
challenge,
nanotechnology
provided
innovative
solutions
formation
by
clinically
relevant
Recent
advances
nanotechnological
strategies,
including
metallic
nanoparticles,
functionalized
dendrimers,
polymeric
cyclodextrin-based
delivery,
solid
lipid
polymer
conjugates,
liposomes,
may
provide
valuable
technological
against
infectious
diseases.
Therefore,
it
is
imperative
conduct
comprehensive
review
summarize
the
recent
advancements
limitations
advanced
nanotechnologies.
present
Review
encompasses
summary
agents,
mechanisms
that
lead
formation,
impact
on
human
health.
In
nutshell,
offers
survey
managing
infections.
A
detailed
presentation
how
these
strategies
improve
control
prevent
key
objective
mechanisms,
applications,
prospects
nanotechnologies
better
understanding
Abstract
Cancer
immunotherapies
have
improved
human
health,
and
one
among
the
important
technologies
for
cancer
immunotherapy
is
vaccine.
Antigens
are
most
components
in
vaccines.
Generally,
antigens
vaccines
can
be
divided
into
two
categories:
pre‐defined
unidentified
antigens.
Although,
loaded
with
predefined
commonly
used,
vaccine
mixed
antigens,
especially
whole
cells
or
cell
lysates,
a
very
promising
approach,
such
obviate
some
limitations
Their
advantages
include,
but
not
limited
to,
inclusion
of
pan‐spectra
(all
kinds
of)
inducing
pan‐clones
specific
T
cells,
overcoming
heterogeneity
cells.
In
this
review,
recent
advances
based
on
whole‐tumor
either
summarized.
terms
focus
applying
water‐soluble
lysates
as
Recently,
utilizing
has
become
feasible.
Considering
that
pre‐determined
antigen‐based
(mainly
peptide‐based
mRNA‐based)
various
limitations,
developing
alternative.
Journal of Nanobiotechnology,
Год журнала:
2024,
Номер
22(1)
Опубликована: Фев. 14, 2024
Abstract
Despite
recent
advancements
in
cancer
treatment,
this
disease
still
poses
a
serious
threat
to
public
health.
Vaccines
play
an
important
role
preventing
illness
by
preparing
the
body's
adaptive
and
innate
immune
responses
combat
diseases.
As
our
understanding
of
malignancies
their
connection
system
improves,
there
has
been
growing
interest
priming
fight
more
effectively
comprehensively.
One
promising
approach
involves
utilizing
nanoparticle
systems
for
antigen
delivery,
which
shown
potentiate
as
vaccines
and/or
adjuvants.
In
review,
we
comprehensively
summarized
immunological
mechanisms
while
focusing
specifically
on
applications
various
types
nanoparticles
field
immunotherapy.
By
exploring
these
breakthroughs,
hope
identify
significant
challenges
obstacles
making
nanoparticle-based
adjuvants
feasible
clinical
application.
This
review
serves
assess
breakthroughs
vaccinations
shed
light
prospects
potential
barriers.
doing
so,
aim
inspire
future
immunotherapies
that
harness
nanotechnology
deliver
effective
targeted
treatments.
Graphical
abstract
Advanced Materials,
Год журнала:
2025,
Номер
unknown
Опубликована: Янв. 10, 2025
Abstract
Cancer
immunotherapy,
which
leverages
immune
system
components
to
treat
malignancies,
has
emerged
as
a
cornerstone
of
contemporary
therapeutic
strategies.
Yet,
critical
concerns
about
the
efficacy
and
safety
cancer
immunotherapies
remain
formidable.
Nanotechnology,
especially
polymeric
nanoparticles
(PNPs),
offers
unparalleled
flexibility
in
manipulation‐from
chemical
composition
physical
properties
precision
control
nanoassemblies.
PNPs
provide
an
optimal
platform
amplify
potency
minimize
systematic
toxicity
broad
spectrum
immunotherapeutic
modalities.
In
this
comprehensive
review,
basics
polymer
chemistry,
state‐of‐the‐art
designs
from
physicochemical
standpoint
for
encompassing
vaccines,
situ
vaccination,
adoptive
T‐cell
therapies,
tumor‐infiltrating
cell‐targeted
antibodies,
cytokine
therapies
are
delineated.
Each
immunotherapy
necessitates
distinctively
tailored
design
strategies
nanoplatforms.
The
extensive
applications
PNPs,
investigation
their
mechanisms
action
enhanced
particularly
focused
on.
profiles
clinical
research
progress
discussed.
Additionally,
forthcoming
developments
emergent
trends
nano‐immunotherapeutics
poised
transform
treatment
paradigms
into
clinics
explored.
Immunological Reviews,
Год журнала:
2023,
Номер
321(1), С. 94 - 114
Опубликована: Авг. 7, 2023
Immunogenic
cell
death
(ICD)
is
a
unique
mode
of
death,
which
can
release
immunogenic
damage-associated
molecular
patterns
(DAMPs)
and
tumor-associated
antigens
to
trigger
long-term
protective
antitumor
immune
responses.
Thus,
amplifying
"eat
me
signal"
during
tumor
ICD
cascade
critical
for
cancer
immunotherapy.
Some
therapies
(radiotherapy,
photodynamic
therapy
(PDT),
photothermal
(PTT),
etc.)
inducers
(chemotherapeutic
agents,
have
enabled
initiate
and/or
facilitate
activate
Recently,
nanostructure-based
drug
delivery
systems
been
synthesized
inducing
through
combining
treatment
chemotherapeutic
photosensitizers
PDT,
transformation
agents
PTT,
radiosensitizers
radiotherapy,
etc.,
loaded
at
an
appropriate
dosage
in
the
designated
place
time,
contributing
higher
efficiency
lower
toxicity.
Also,
immunotherapeutic
combination
with
produce
synergetic
effects,
thus
potentiating
Overall,
our
review
outlines
emerging
inducers,
nanostructure
loading
diverse
evoke
chemoradiotherapy,
PTT
or
agents.
Moreover,
we
discuss
prospects
challenges
harnessing
induction-based
immunotherapy,
highlight
significance
multidisciplinary
interprofessional
collaboration
promote
optimal
translation
this
strategy.
ACS Nano,
Год журнала:
2023,
Номер
17(11), С. 9826 - 9849
Опубликована: Май 19, 2023
The
development
of
nanovaccines
that
employ
polymeric
delivery
carriers
has
garnered
substantial
interest
in
therapeutic
treatment
cancer
and
a
variety
infectious
diseases
due
to
their
superior
biocompatibility,
lower
toxicity
reduced
immunogenicity.
Particularly,
stimuli-responsive
nanocarriers
show
great
promise
for
delivering
antigens
adjuvants
targeted
immune
cells,
preventing
antigen
degradation
clearance,
increasing
the
uptake
specific
antigen-presenting
thereby
sustaining
adaptive
responses
improving
immunotherapy
certain
diseases.
In
this
review,
most
recent
advances
utilization
stimulus-responsive
polymer-based
immunotherapeutic
applications
are
presented.
These
sophisticated
with
diverse
functions,
aimed
at
administration
disease
prevention
immunotherapy,
further
classified
into
several
active
domains,
including
pH,
temperature,
redox,
light
ultrasound-sensitive
intelligent
nanodelivery
systems.
Finally,
potential
strategies
future
design
multifunctional
next-generation
by
integrating
materials
science
biological
interface
proposed.
Biomedicine & Pharmacotherapy,
Год журнала:
2023,
Номер
170, С. 115992 - 115992
Опубликована: Дек. 9, 2023
Cancer
vaccines
hold
considerable
promise
for
the
immunotherapy
of
solid
tumors.
Nanomedicine
offers
several
strategies
enhancing
vaccine
effectiveness.
In
particular,
molecular
or
(sub)
cellular
can
be
delivered
to
target
lymphoid
tissues
and
cells
by
nanocarriers
nanoplatforms
increase
potency
durability
antitumor
immunity
minimize
negative
side
effects.
Nanovaccines
use
nanoparticles
(NPs)
as
carriers
and/or
adjuvants,
offering
advantages
optimal
nanoscale
size,
high
stability,
ample
antigen
loading,
immunogenicity,
tunable
presentation,
increased
retention
in
lymph
nodes,
promotion.
To
induce
immunity,
cancer
rely
on
tumor
antigens,
which
are
administered
form
entire
cells,
peptides,
nucleic
acids,
extracellular
vesicles
(EVs),
cell
membrane–encapsulated
NPs.
Ideal
stimulate
both
humoral
while
overcoming
tumor-induced
immune
suppression.
Herein,
we
review
key
properties
nanovaccines
highlight
recent
advances
their
development
based
structure
composition
various
(including
synthetic
semi
(biogenic)
nanocarriers.
Moreover,
discuss
cell–derived
those
whole-tumor-cell
components,
EVs,
NPs,
hybrid
membrane–coated
NPs),
nanovaccine
action
mechanisms,
challenges
immunocancer
therapy
translation
clinical
applications.